Cell-Cycle Reprogramming for PI3K Inhibition Overrides a Relapse-Specific C481S <i>BTK</i> Mutation Revealed by Longitudinal Functional Genomics in Mantle Cell LymphomaDavid Chiron, Selina Chen‐Kiang, Christopher E. Mason et al.|Cancer Discovery|2014Cited by 272
A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphomaPeter Martin, John P. Leonard, Nancy L. Bartlett et al.|Blood|2019Cited by 84
Induction of prolonged early G<sub>1</sub>arrest by CDK4/CDK6 inhibition reprograms lymphoma cells for durable PI3Kδ inhibition through PIK3IP1David Chiron, Selina Chen‐Kiang, Maurizio Di Liberto et al.|Cell Cycle|2013Cited by 72
A phase I trial of palbociclib plus bortezomib in previously treated mantle cell lymphomaPeter Martin, John P. Leonard, Jia Ruan et al.|Leukemia & lymphoma/Leukemia and lymphoma|2019Cited by 27
Targeting CDK4/6 in mantle cell lymphomaChristina Y. Lee, Selina Chen‐Kiang, Xiangao Huang et al.|Annals of Lymphoma|2020Cited by 19